Preview: TELA Bio's Earnings
Portfolio Pulse from Benzinga Insights
TELA Bio (NASDAQ:TELA) is scheduled to release its quarterly earnings report on March 21, 2024. Analysts predict an EPS of $-0.43. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing subsequent share price drops. Over the last year, TELA Bio's shares have decreased by 46.45%, indicating a negative trend for long-term shareholders. Investors will be closely watching for not only the earnings results but also the company's future guidance.
March 20, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TELA Bio is expected to report an EPS of $-0.43 for the upcoming quarter. Historical data shows that despite beating EPS estimates, the company's share price has often dropped following earnings announcements. With a 46.45% decrease in share price over the last year, investor sentiment may be low.
Given TELA Bio's history of beating EPS estimates but experiencing subsequent share price declines, and considering the overall negative trend in share price over the past year, it is likely that the stock may face short-term downward pressure following the earnings announcement. The anticipation of future guidance will also play a critical role in investor reactions.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100